Tag
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC
Neimeth International Pharmaceuticals Plc has seen its share price jump by over 45% week-to-date on the Nigerian Exchange following its 66th Annual General Meeting (AGM), where capital-raising and expansion plans were adopted.
The Board of Directors of Neimeth International Pharmaceuticals Plc has announced the appointment of Mr. Christopher Oshiafi as chairman of the company.
The shareholders of the company approved a capital raise for N5 billion in 2022, the sum of N3.7 billion through a Rights Issue while N1.3 billion will be raised through private placement.
Neimeth said it received no objection from SEC on the allotment of 2,373,947,500 ordinary shares at N1.55 per share.
Neimeth has disclosed a plan to raise more capital through right issue and private placement to be used for a two-pronged expansion plan
Three Nigerian companies have gotten shareholders’ approval to raise about N58.6 billion this year from rights issues.
Neimeth International Pharmaceuticals Plc has explained how it plans to raise an additional capital of N5 billion that...
Neimeth has proposed a total final dividend of N123.45 million to be distributed to the shareholders of the company.
While Femi Otedola's exit from @forteoilng was major news last week, @oando_plc vs @secnigeria court case resumes next week
Thomas Wyatt Plc led the gainers this week on the Nigerian Stock Exchange (NSE) appreciating by 24%.
Neimeth International Pharmaceuticals Plc closed its books for the quarter with an impressive half-year financial scorecard, showing the highest revenue recorded in the corresponding period in the last six years.
Beta Glass Plc led the top 10 gainers on the Nigerian Stock Exchange for the trading week ended May 10. 2019. The stock appreciated by 23.1% to close at N68.95.